A rare case of a solitary extramedullary plasmacytoma of the palatine tonsil by Suska, Anna et al.
CLINICAL IMAGE Solitary extramedullary plasmacytoma of palatine tonsil 201
Radiograms showed no osteolytic lesion. Bone 
marrow trephine biopsy findings were typical 
for normal hematopoiesis (FIGURE 1E), with dis‑
persed CD138+ plasma cells representing 1% of 
total bone marrow cells, and no light ‑chain re‑
striction (Supplementary material, Figures S4 –S6). 
Magnetic resonance imaging of the head and neck 
showed an exophytic lesion communicating with 
the left palatine tonsil, attached tightly to the up‑
per esophageal sphincter and longus colli mus‑
cle (FIGURE 1F). A focal increase in 18F ‑fluoroethyl‑
‑tyrosine (18F ‑FET) uptake in the left palatine ton‑
sil was observed on positron ‑emission tomogra‑
phy–computed tomography (PET ‑CT) (FIGURE 1G). 
Based on those findings, the patient was diag‑
nosed with solitary extramedullary plasmacyto‑
ma. Considering the locally advanced neoplastic 
process, the patient was not considered eligible 
for tonsillectomy but underwent radiotherapy 
A 48 ‑year ‑old man, without a past medical histo‑
ry, was admitted to the emergency department 
due to a spontaneous bleeding from the pharynx. 
Coagulation parameters were normal. Dental ex‑
amination excluded bleeding from periodontal tis‑
sue. Ear, nose, and throat examination revealed 
bleeding from the tumor of the left palatine ton‑
sil. Histopathologic examination of the biopsy 
specimen showed infiltrate composed of plas‑
ma cells (FIGURE 1A). Immunophenotyping demon‑
strated a positive reaction to CD38, CD56, and 
CD138 (Supplementary material, Figures S1–S3), 
and κ light ‑chain restriction (FIGURE 1B). Addition‑
ally, a few c ‑Myc–positive cells were observed 
(FIGURE 1C). The result of Epstein–Barr virus–en‑
coded small RNA in situ hybridization was nega‑
tive (FIGURE 1D). No monoclonal protein was found 
on serum protein electrophoresis and immuno‑
fixation. No protein was detected on urinalysis. 
CLINICAL IMAGE
A rare case of a solitary extramedullary 
plasmacytoma of the palatine tonsil
Anna Suska1, Bogdan Małkowski2, Krzysztof Halaszka3, Krystyna Gałązka4, Maciej R. Czerniuk5, 
Artur Jurczyszyn1
1  Department of Hematology, Jagiellonian University Medical College, Kraków, Poland
2  Department of Nuclear Medicine, Franciszek Lukaszczyk Oncology Centre, Bydgoszcz, Poland
3  Department of Tumor Pathology, Maria Sklodowska ‑Curie Institute – Oncology Center, Krakow Branch, Kraków, Poland
4  Department of Pathomorphology, Jagiellonian University Medical College, Kraków, Poland
5  Department of Oral Surgery, Medical University of Warsaw, Warsaw, Poland
Correspondence to:
Artur Jurczyszyn, MD, PhD, 
Department of Hematology, 
Jagiellonian University Medical 
College, ul. Kopernika 17,  
31‑501 Kraków, Poland,  
phone: +48 12 424 74 26,  
email: mmjurczy@cyf ‑kr.edu.pl
Received: November 18, 2018.
Revision accepted:  
December 31, 2018.
Published online: January 4, 2019.
Pol Arch Intern Med. 2019; 
129 (3): 201‑203
doi:10.20 452/pamw.4415
Copyright by Medycyna Praktyczna, 
Kraków 2019
A B
FIGURE 1 A, B – histopathologic analysis of biopsy specimens from the left palatine tonsil tumor: A – infiltrate 
composed of small and medium ‑sized cells with plasma cell morphology, eosinophilic cytoplasm and round nuclei with 
fine ‑grained chromatin. Some cells show a nuclear polymorphism with larger nuclei and single eosinophilic nucleoli. 
Hematoxylin and eosin staining, magnification ×400; B – positive immunohistochemical reaction to light ĸ chains, 
magnification ×100
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with no sign of a systemic disease.1 EMPs are 
found primarily in the head and neck region, es‑
pecially in the sinonasal area; however, any other 
site can be affected as well.2 EMPs are more com‑
mon in men, with a peak incidence in the sixth 
decade of life.3 In differential diagnosis, reactive 
processes, carcinoma, and lymphoma should be 
with a total dose of 54 Gy in 27 fractions. Cur‑
rently, 5 months after the radiotherapy, the pa‑
tient remains without progression. No increase 
in the standardized uptake value was found on 
follow ‑up PET ‑CT (FIGURE 1H).
Solitary extramedullary plasmacytoma (EMP) 
is a rare plasma cell tumor involving soft tissues, 
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FIGURE 1 C, D – histopathologic analysis of biopsy specimens from the left palatine tonsil tumor: positive 
immunohistochemical reaction to C ‑Myc in a few cells (C; magnification × 200); negative Epstein–Barr virus–encoded 
small RNA in situ hybridization, (D; magnification × 200); E – bone marrow trephine biopsy; findings typical for normal 
hematopoiesis, without a pathological infiltrate; hematoxylin and eosin staining, magnification × 200; F – magnetic 
resonance imaging of the head and neck in the axial plane; an exophytic lesion with irregular contours in the left dorsal 
oropharynx, communicating with the left palatine tonsil, extending downwards the epiglottis, with the largest cross‑
‑sectional dimension of 21 mm × 24 mm at the uvula level, tightly attached to the upper esophageal sphincter and 
longus colli muscle, without invasion of adjacent structures; moderately restricted diffusion with the postcontrast 
enhancement (arrow); G, H – fusion positron ‑emission tomography in the axial plane: G – focal increase in 
18F ‑fluoroethyl ‑tyrosine uptake in the left palatine tonsil, extending onto the lateral wall of the throat, with a maximum 
standardized uptake value of 3.38 (arrow); H – no focal increase in 18F‑fluoroethyl‑tyrosine uptake in the left palatine tonsil
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considered. Diagnostic criteria include clonal plas‑
ma cell infiltration in the biopsy specimen, lack 
of clonal plasma cells in trephine biopsy, nor‑
mal skeletal survey, and no features of end ‑organ 
damage.4 Imaging studies should include mag‑
netic resonance imaging to determine the extent 
of local disease and PET ‑CT to exclude system‑
ic involvement.4 During the latter examination, 
18F ‑FET should be used as a tracer as it exhibits 
no uptake in inflammatory cells, which makes it 
a more specific marker of neoplastic cells than 
18F ‑fluorodeoxyglucose.5 Treatment is local. Ra‑
diotherapy has been considered a cornerstone, 
but the essential role of surgical treatment has 
been also highlighted.3 Surgery combined with ir‑
radiation was shown to be associated with a sur‑
vival benefit when compared with either surgi‑
cal treatment or radiotherapy alone. In patients 
with unresectable tumors, radiotherapy (at least 
45 Gy) should be the treatment of choice. Con‑
sidering the risk of local progression and myelo‑
ma relapse, a follow ‑up is required.3 
SUPPLEMENTARY MATERIAL
Supplementary material is available with the article at www.mp.pl/paim.
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